The Debate Isn't About Vaccines — It's About Methodology
Much of the controversy centers on a research approach known as the test-negative design.
This method compares people who seek medical care for respiratory illnesses. Researchers then examine who tests positive for COVID-19 and who doesn't, while also looking at vaccination status.
Supporters argue that the approach has been used for decades and remains one of the best tools available for generating real-world vaccine effectiveness estimates quickly.
Critics, however, believe the method can be influenced by hidden variables that may affect the accuracy of the results.
The disagreement highlights a broader debate within public health circles: how should scientists evaluate vaccine performance in a world where most people have already been exposed to the virus, vaccinated, or both?
